PR Newswire | Dec 2, 2021 04:31PM EST

Monday, December 6

12/02 15:30 CST

CTI BioPharma to Present at the JMP Securities Hematology & Oncology Summit on Monday, December 6 SEATTLE, Dec. 2, 2021

SEATTLE, Dec. 2, 2021 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the JMP Securities Hematology & Oncology Summit at 3:40 p.m. ET. The conference will be held in a virtual meeting format.

Presentation details: Event: JMP Securities Hematology & Oncology Summit Date: Monday, December 6, 2021 Time: 3:40 p.m. ET

The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma's website at www.ctibiopharma.com.

About CTI BioPharma Corp.We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on developing and commercializing pacritinib, our product candidate currently in active late-stage development. We are headquartered in Seattle, Washington.

CTI BioPharma Investor Contacts:Argot Partners +212-600-1902 cti@argotpartners.com

View original content to download multimedia: https://www.prnewswire.com/news-releases/cti-biopharma-to-present-at-the-jmp-securities-hematology--oncology-summit-on-monday-december-6-301436710.html

SOURCE CTI BioPharma Corp.